SAB Biotherapeutics, Inc. (SABS): 424B5 filed Mar 19, 2026

Form type

424B5

Filing date

Mar 19, 2026

Accession number

0001193125-26-114728

Filer

SAB Biotherapeutics, Inc. (CIK 1833214)